These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33252581)

  • 1. EFFECTS OF GLYCEMIC VARIABILITY ON THE PROGRESSION OF DIABETIC RETINOPATHY AMONG PATIENTS WITH TYPE 2 DIABETES.
    Park JY; Hwang JH; Kang MJ; Sim HE; Kim JS; Ko KS
    Retina; 2021 Jul; 41(7):1487-1495. PubMed ID: 33252581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-Relations between Dietary Patterns and Glycemic Control-Related Biomarkers on Risk of Retinopathy in Type 2 Diabetes.
    Wu YJ; Hsu CC; Hwang SJ; Lin KD; Lin PC; Huang YF; Lee CH; Chang CI; Huang MC
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.
    Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J
    J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China.
    Liu Y; Yang J; Tao L; Lv H; Jiang X; Zhang M; Li X
    BMJ Open; 2017 Sep; 7(9):e016280. PubMed ID: 28864696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.
    Zehetner C; Kirchmair R; Kralinger M; Kieselbach G
    Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.
    Foo V; Quah J; Cheung G; Tan NC; Ma Zar KL; Chan CM; Lamoureux E; Tien Yin W; Tan G; Sabanayagam C
    J Diabetes; 2017 Feb; 9(2):200-207. PubMed ID: 27043025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study.
    Pan J; Li Q; Zhang L; Jia L; Tang J; Bao Y; Jia W
    J Diabetes Complications; 2014; 28(6):772-8. PubMed ID: 25073934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between diabetic retinopathy, glycemic control, risk factor indicators and patient education.
    Axer-Siegel R; Herscovici Z; Gabbay M; Mimouni K; Weinberger D; Gabbay U
    Isr Med Assoc J; 2006 Aug; 8(8):523-6. PubMed ID: 16958239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with "well-controlled" blood glucose.
    Jin P; Peng J; Zou H; Wang W; Fu J; Shen B; Bai X; Xu X; Zhang X
    PLoS One; 2015; 10(4):e0123449. PubMed ID: 25849536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study.
    Osataphan S; Chalermchai T; Ngaosuwan K
    J Diabetes; 2017 Mar; 9(3):267-274. PubMed ID: 27092709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.
    Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    Diabetes Res Clin Pract; 2011 Feb; 91(2):e40-2. PubMed ID: 21035886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy.
    Gholamhossein Y; Behrouz H; Asghar Z
    Korean J Ophthalmol; 2014 Oct; 28(5):373-8. PubMed ID: 25276078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus.
    Song KH; Jeong JS; Kim MK; Kwon HS; Baek KH; Ko SH; Ahn YB
    J Diabetes Investig; 2019 May; 10(3):745-752. PubMed ID: 30300472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients.
    Hu G; Gu L; Wang R; Jian Q; Lv K; Xia M; Lai M; Shen T; Hu J; Yang S; Ye C; Zhang X; Wang Y; Xu X; Zhang F
    Sci Bull (Beijing); 2024 Jun; 69(12):1920-1935. PubMed ID: 38423871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal main vessel calibers and systemic markers for long-term development of proliferative diabetic retinopathy.
    Dinesen S; Stokholm L; Subhi Y; Henriksen JE; Savarimuthu TR; Peto T; Grauslund J
    Acta Ophthalmol; 2024 Jun; 102(4):448-454. PubMed ID: 37803999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitudinal cohort study in GoDARTS.
    Liu Y; Wang M; Morris AD; Doney AS; Leese GP; Pearson ER; Palmer CN
    Diabetes Care; 2013 Dec; 36(12):3979-84. PubMed ID: 24170761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).
    Raman R; Gupta A; Kulothungan V; Sharma T
    Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for progression of diabetic retinopathy in Alberta First Nations communities.
    Rudnisky CJ; Wong BK; Virani H; Tennant MTS
    Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S19-S29. PubMed ID: 29074008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.